These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 227634)

  • 1. In vitro transfer of specific reactivity to cytomegalovirus and candida to cord blood leukocytes with dialyzable leukocyte extracts.
    Sirianni MC; Fiorilli M; Paná A; Pezzella M; Aiuti F
    Clin Immunol Immunopathol; 1979 Nov; 14(3):300-6. PubMed ID: 227634
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of cell-mediated responses with dialyzable leukocyte extract containing transfer factor.
    Klesius PH
    Adv Exp Med Biol; 1981; 137():293-323. PubMed ID: 6174037
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro transfer of immunity against PPD with dialyzable extract of leukocytes from human colostrum].
    Martínez-Cairo Cueto S; Alasio-Chávez C; Dávila Velázquez JR
    Rev Alerg; 1992; 39(6):126-32. PubMed ID: 1492196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine dialyzable lymph node extracts have antigen-dependent and antigen-independent effects on human cell-mediated immunity in vitro.
    Wilson GB; Newell RT; Burdash NM
    Cell Immunol; 1979 Sep; 47(1):1-18. PubMed ID: 315822
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of human leukocyte dialysates containing transfer factor in the direct leukocyte migration inhibition (LMI) assay.
    Borkowsky W; Lawrence HS
    J Immunol; 1979 Oct; 123(4):1741-8. PubMed ID: 479597
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoregulatory factors derived from human tumors. I. Immunologic and biochemical characterization of factors that suppress lymphocyte proliferative and cytotoxic responses in vitro.
    Roth JA; Grimm EA; Gupta RK; Ames RS
    J Immunol; 1982 May; 128(5):1955-62. PubMed ID: 6460814
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy with dialyzable leukocyte extracts and studies of their antigen-specific (transfer factor) activity.
    Fudenberg HH; Wilson GB; Smith CL
    Proc Virchow Pirquet Med Soc; 1980 Dec; 34():3-87. PubMed ID: 6270691
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dialyzable leukocyte extracts (DLEs) with transfer factor activity on leukocyte migration in vitro. III. Characterization of the antigen-independent migration inhibition factor in DLEs as a neutrophil immobilizing factor.
    Wilson GB; Smith CL; Fudenberg HH
    J Allergy Clin Immunol; 1979 Jul; 64(1):56-66. PubMed ID: 447952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract.
    Sen P; Smith JK; Buse M; Hsieh HC; Lavenhar MA; Lintz D; Louria DB
    Sabouraudia; 1982 Jun; 20(2):85-93. PubMed ID: 7051369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Migration and chemotaxis of donor leukocytes modified by serum of psoriasis patients and psoriasis scale extracts].
    Schwartze G; Wozniak KD; Wohlrab W; Höfer HW
    Dermatol Monatsschr; 1984; 170(10):637-41. PubMed ID: 6510540
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical analysis of dialyzable leukocyte extracts.
    Gottlieb AA; Saito K; Sutcliffe S; Foster LA; Tamaki N; Maziarz G; Sutherland C; Brennessel B
    J Reticuloendothel Soc; 1977 Jun; 21(6):403-16. PubMed ID: 886545
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of maternal and fetal leukocyte migration test after normal deliveries; the role of maternal and fetal serum in the leukocyte migration assay.
    Komlos L; Halbrecht I; Goldman J
    Reproduccion; 1982; 6(3-4):141-50. PubMed ID: 7152087
    [No Abstract]   [Full Text] [Related]  

  • 14. Blocking effect of human T lymphocyte extracts on E-rosette inhibition by sheep red cell fragments.
    Okuda N; Moriya N; Miyawaki T; Nagaoki T; Kato E
    Clin Immunol Immunopathol; 1977 May; 7(3):372-8. PubMed ID: 326450
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition.
    Wilson GB; Fudenberg HH; Bahm VJ
    Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tissue extracts of malignant human lymphomas in the leukocyte migration test].
    Schwalbe P; Arndt D; Müller-Hermelink HK
    Acta Biol Med Ger; 1978; 37(7):1105-12. PubMed ID: 747042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of cell-mediated immunity to Paracoccidioides brasiliensis in hamsters with dialysable leukocyte extracts.
    Peraçoli MT; Montenegro MR; Soares AM; Mota NG
    J Med Vet Mycol; 1990; 28(1):35-46. PubMed ID: 1694543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithymus cell activity of nephritogenic antibodies.
    Bakker WW; Bagchus WM; Hoedemaeker PJ
    Transplantation; 1979 Mar; 27(3):217-8. PubMed ID: 155336
    [No Abstract]   [Full Text] [Related]  

  • 19. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Schmeisser G; Kademann J
    Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of delayed hypersensitivity to nonsensitive human leukocytes with rhesus-monkey lymphoid RNA extracts.
    Paque RE; Dray S
    Transplant Proc; 1974 Jun; 6(2):203-7. PubMed ID: 4208757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.